SEA Vision has announced the launch of HarleNir, a near-infrared hyperspectral vision (NIR)system. Based on the company's Harlequin blister control system, HarleNIR is a new generation of blister inspection technology that goes beyond visible inspection to provide a chemical analysis of drug products.
Paolo Landriani, Business Development Manager at SEA Vision, said: “We have been designing inspection system for quality control for more than 20 years and this latest technology allows us to take inspection processes to the next level.
“Through integrated imaging technology, HarleNIR can distinguish products directly from their active ingredients and perform a chemical analysis to identify compounds with different active principle, different dosage or measure the active ingredient uniformity distribution inside products.
“In an era of increasing regulation and quality control, the industry needs to improve inspection methods. Systems like HArleNIR provide extra peace of mind for drug manufacturers.”
HarleNIR can inspect an entire batch on the manufacturing line in a fully automated fashion, removing human error and speeding up batch release times. "Even if a product appears visually sound, errors in the API can now be identified," the company said in a statement.
Headquartered in Pavia, Italy, SEA is a vision systems provider for pharmaceutical companies and OEMs. The company will be on stand 4F22 at CPhI Worldwide exhibiting alongside packaging machine manufacturer Marchesini Group.
